143 related articles for article (PubMed ID: 10850375)
1. Systemic and coronary hemodynamic effects of JTV-506, a novel potassium channel opener, in conscious dogs: comparison with cromakalim and nicorandil.
Zhang S; Sakai K; Hasuo H; Furuta K; Ureshino H; Shibata O; Sumikawa K
Res Commun Mol Pathol Pharmacol; 1999; 105(1-2):115-27. PubMed ID: 10850375
[TBL] [Abstract][Full Text] [Related]
2. Effects of the new potassium channel opener JTV-506 on coronary vessels in vitro and in vivo.
Hirata Y; Kanada A; Miyai H; Mabuchi Y; Aisaka K
Arzneimittelforschung; 1999 Mar; 49(3):199-206. PubMed ID: 10219462
[TBL] [Abstract][Full Text] [Related]
3. Cardiovascular pharmacological studies on JTV-506, a new potassium channel opener. 2nd communication: effects on blood pressure in conscious animals.
Hirata Y; Suzuki Y; Miyai H; Aisaka K
Arzneimittelforschung; 2000 Apr; 50(4):333-40. PubMed ID: 10800631
[TBL] [Abstract][Full Text] [Related]
4. Effects of a K+ATP channel opener, lemakalim, on systemic, coronary and regional vascular dynamics in conscious dogs: comparison with nifedipine, adenosine, nitroglycerin and acetylcholine.
Shen YT; Vatner SF
J Pharmacol Exp Ther; 1993 May; 265(2):1026-37. PubMed ID: 8496801
[TBL] [Abstract][Full Text] [Related]
5. Cardiovascular pharmacological studies on JTV-506, a new potassium channel opener. 1st communication: effects on myocardium and vasculature.
Hirata Y; Suzuki Y; Miyai H; Aisaka K
Arzneimittelforschung; 2000 Mar; 50(3):236-43. PubMed ID: 10758774
[TBL] [Abstract][Full Text] [Related]
6. [Effects of a novel KATP channel opener JTV-506 on myocardial infarct size of isolated rat heart].
Jia DL; Zheng XW; Qi GX; Hu J; Zeng DY
Yao Xue Xue Bao; 2000 Oct; 35(10):743-6. PubMed ID: 11372439
[TBL] [Abstract][Full Text] [Related]
7. K+ channel-opening action contributes to the preventive effects of nicorandil on U46619-induced vasoconstriction of canine large coronary arteries in vivo.
Kamijo T; Iwai T; Haruta K; Takeda K
Arch Int Pharmacodyn Ther; 1996; 331(3):273-84. PubMed ID: 9124999
[TBL] [Abstract][Full Text] [Related]
8. Effects of JTV-506, a new K+ channel activator, on airway smooth muscle contraction and systemic blood pressure.
Ando T; Kume H; Urata Y; Takagi K
Clin Exp Allergy; 1997 Jun; 27(6):705-13. PubMed ID: 9208193
[TBL] [Abstract][Full Text] [Related]
9. Effect of JTV-506, a novel vasodilator, on coronary blood flow in conscious dogs.
Hirata Y; Aisaka K
J Cardiovasc Pharmacol; 1997 Mar; 29(3):397-405. PubMed ID: 9125679
[TBL] [Abstract][Full Text] [Related]
10. Effect of the new nitrate ester ITF 296 on coronary and systemic hemodynamics in the conscious dog: comparison with nitroglycerin and nicorandil.
Ueno A; Bergamaschi M; Gromo G; Nonaka K; Mizrahi J
J Cardiovasc Pharmacol; 1995; 26 Suppl 4():S13-20. PubMed ID: 8839221
[TBL] [Abstract][Full Text] [Related]
11. Cardiovascular profile of RWJ 29009, a new potassium channel activator, in anesthetized and conscious dogs.
Damiano BP; Giardino EC; Haertlein BJ; Stump GL; Mitchell JA; Falotico R
J Cardiovasc Pharmacol; 1994 Feb; 23(2):300-10. PubMed ID: 7511761
[TBL] [Abstract][Full Text] [Related]
12. Interaction of isoflurane and cromakalim, a KATP channel opener, on coronary and systemic haemodynamics in chronically instrumented dogs.
Sakai K; Zhang S; Ureshino H; Tomiyasu S; Sumikawa K
Acta Anaesthesiol Scand; 2000 Oct; 44(9):1122-7. PubMed ID: 11028734
[TBL] [Abstract][Full Text] [Related]
13. K+ channel opening mediates the vasorelaxant effects of nicorandil in the intact vascular system.
Cavero I; Pratz J; Mondot S
Z Kardiol; 1991; 80 Suppl 7():35-41. PubMed ID: 1838848
[TBL] [Abstract][Full Text] [Related]
14. Cardiovascular effects of KRN2391 in anesthetized dogs: a comparison with cromakalim and nitroglycerin.
Kaneta S; Yokoyama T; Izumi H; Izawa T; Ogawa N
Arch Int Pharmacodyn Ther; 1994; 327(2):184-93. PubMed ID: 7979827
[TBL] [Abstract][Full Text] [Related]
15. Hemodynamic and hormonal responses to nicorandil in a canine model of acute ischemic heart failure: a comparison with cromakalim and nitroglycerin.
Kamijo T; Kamei K; Sugo I; Kamiyama T; Sudo H; Ohba Y
J Cardiovasc Pharmacol; 1999 Jan; 33(1):93-101. PubMed ID: 9890402
[TBL] [Abstract][Full Text] [Related]
16. Effects of cromakalim and pinacidil on large epicardial and small coronary arteries in conscious dogs.
Giudicelli JF; la Rochelle CD; Berdeaux A
J Pharmacol Exp Ther; 1990 Nov; 255(2):836-42. PubMed ID: 2173761
[TBL] [Abstract][Full Text] [Related]
17. Cardiovascular effects of the novel potassium channel opener (3S,4R)-3-hydroxy-2,2-dimethyl-4-(2-oxo- 1-pyrrolidinyl)-6-phenylsulfonylchromane hemihydrate.
Linz W; Klaus E; Albus U; Becker R; Mania D; Englert HC; Schölkens BA
Arzneimittelforschung; 1992 Oct; 42(10):1180-5. PubMed ID: 1472138
[TBL] [Abstract][Full Text] [Related]
18. Effects of 2-nicotinamidethyl nitrate (SG-75) and/or nitroglycerin on systemic hemodynamics and coronary blood flow in conscious dogs.
Mizukami M; Tomoike H; Inouh T; Watanabe K; Kikuchi Y; Nakamura M
Arzneimittelforschung; 1981; 31(8):1244-7. PubMed ID: 6457606
[TBL] [Abstract][Full Text] [Related]
19. Effects of nicorandil, a new antianginal agent, and nifedipine on collateral blood flow in a chronic coronary occlusion model.
Lamping KA; Warltier DC; Hardman HF; Gross GJ
J Pharmacol Exp Ther; 1984 May; 229(2):359-63. PubMed ID: 6232374
[TBL] [Abstract][Full Text] [Related]
20. RWJ 26629, a new potassium channel opener and vascular smooth muscle relaxant: a potential antihypertensive and antianginal agent.
Katz LB; Giardino EC; Salata JJ; Moore JB; Falotico R
J Pharmacol Exp Ther; 1993 Nov; 267(2):648-56. PubMed ID: 8246137
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
